Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EQB Inc. stock logo
EQB
EQB
C$88.80
-0.2%
C$86.47
C$57.92
C$97.64
C$3.39B1.6761,892 shs39,391 shs
GOR
38698 (GOR.V)
C$0.00
C$0.00
C$0.02
N/AN/A11,568 shsN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
$15.47
+0.2%
$15.17
$13.51
$16.74
$6.19M0.659,787 shs1,770 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$26.90
-2.3%
$38.12
$26.30
$63.57
$3.21B1.91.47 million shs1.13 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EQB Inc. stock logo
EQB
EQB
+0.67%+5.60%+7.28%-1.61%+52.01%
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
+0.46%+2.25%+3.62%-2.65%+2.80%
10x Genomics, Inc. stock logo
TXG
10x Genomics
-0.22%-5.62%-24.21%-35.09%-46.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
EQB Inc. stock logo
EQB
EQB
3.4918 of 5 stars
3.40.01.70.01.81.72.5
GOR
38698 (GOR.V)
N/AN/AN/AN/AN/AN/AN/AN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/AN/AN/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.1494 of 5 stars
3.41.00.04.82.53.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EQB Inc. stock logo
EQB
EQB
2.70
Moderate BuyC$102.5615.49% Upside
GOR
38698 (GOR.V)
N/AN/AN/AN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
0.00
N/A$17.8615.44% Upside
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.89
Moderate Buy$60.22123.87% Upside

Current Analyst Ratings

Latest GOR, TXG, SEA, and EQB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
4/10/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $45.00
4/1/2024
EQB Inc. stock logo
EQB
EQB
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$100.00
3/1/2024
EQB Inc. stock logo
EQB
EQB
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$101.00 ➝ C$107.00
3/1/2024
EQB Inc. stock logo
EQB
EQB
Veritas Investment Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingReduce
2/29/2024
EQB Inc. stock logo
EQB
EQB
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector PerformC$98.00 ➝ C$95.00
2/28/2024
EQB Inc. stock logo
EQB
EQB
National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform Market Weight ➝ Sector Perform Market Weight
2/20/2024
EQB Inc. stock logo
EQB
EQB
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$99.00 ➝ C$111.00
2/16/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$68.00 ➝ $63.00
1/25/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$45.00 ➝ $55.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EQB Inc. stock logo
EQB
EQB
C$1.12B3.03C$55.94 per share1.59C$71.34 per share1.24
GOR
38698 (GOR.V)
N/AN/AN/AN/AN/AN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M5.18N/AN/A$6.22 per share4.32

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EQB Inc. stock logo
EQB
EQB
C$437.51MC$9.319.540.3439.67%14.70%0.76%5/7/2024 (Estimated)
GOR
38698 (GOR.V)
N/AN/A0.00N/AN/AN/AN/AN/A7/4/2024 (Estimated)
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/AN/A2.11N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.17N/AN/AN/A-41.17%-28.82%-22.67%4/30/2024 (Confirmed)

Latest GOR, TXG, SEA, and EQB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.46N/A+$0.46N/AN/AN/A  
3/27/2024Q1 2024
EQB Inc. stock logo
EQB
EQB
N/AC$2.70+C$2.70C$2.74N/AN/A
2/28/2024Q4 2023
EQB Inc. stock logo
EQB
EQB
C$3.63C$2.70-C$0.93C$2.74N/AC$298.77 million
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EQB Inc. stock logo
EQB
EQB
C$1.681.89%N/A18.05%N/A
GOR
38698 (GOR.V)
N/AN/AN/AN/AN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
$2.5916.74%N/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest GOR, TXG, SEA, and EQB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/28/2024
EQB Inc. stock logo
EQB
EQB
QuarterlyC$0.421.95%3/14/20243/15/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EQB Inc. stock logo
EQB
EQB
N/AN/AN/A
GOR
38698 (GOR.V)
N/AN/AN/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
4.69
4.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
EQB Inc. stock logo
EQB
EQB
23.49%
GOR
38698 (GOR.V)
N/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
EQB Inc. stock logo
EQB
EQB
29.03%
GOR
38698 (GOR.V)
N/A
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
10.65%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
EQB Inc. stock logo
EQB
EQB
1,80038.17 millionN/ANot Optionable
GOR
38698 (GOR.V)
147,000N/AN/ANot Optionable
U.S. Global Sea to Sky Cargo ETF stock logo
SEA
U.S. Global Sea to Sky Cargo ETF
N/A400,000N/ANot Optionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

GOR, TXG, SEA, and EQB Headlines

SourceHeadline
10x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $26.4810x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $26.48
marketbeat.com - April 25 at 3:44 PM
10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Moderate Buy" by Brokerages10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Moderate Buy" by Brokerages
americanbankingnews.com - April 25 at 1:38 AM
Down -23.92% in 4 Weeks, Heres Why 10x Genomics (TXG) Looks Ripe for a TurnaroundDown -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
zacks.com - April 24 at 10:36 AM
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
zacks.com - April 23 at 11:06 AM
10x Genomics (TXG) Set to Announce Earnings on Tuesday10x Genomics (TXG) Set to Announce Earnings on Tuesday
americanbankingnews.com - April 23 at 4:54 AM
10x Genomics (TXG) to Release Earnings on Tuesday10x Genomics (TXG) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:47 AM
10x Genomics (TXG) Upgraded to Buy: Heres What You Should Know10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
zacks.com - April 22 at 1:01 PM
First Week of TXG June 21st Options TradingFirst Week of TXG June 21st Options Trading
nasdaq.com - April 21 at 3:32 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $55.0010x Genomics (NASDAQ:TXG) PT Lowered to $55.00
americanbankingnews.com - April 20 at 4:32 AM
10x Genomics (NASDAQ:TXG) Shares Gap Down  on Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down on Analyst Downgrade
americanbankingnews.com - April 19 at 1:14 AM
Bruker to acquire Nanostring for $393MBruker to acquire Nanostring for $393M
medtechdive.com - April 18 at 3:02 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down  Following Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade
marketbeat.com - April 18 at 10:35 AM
10x Genomics, Inc. (TXG)10x Genomics, Inc. (TXG)
finance.yahoo.com - April 17 at 12:34 PM
10x Genomics (NASDAQ:TXG) Trading Down 5.9%10x Genomics (NASDAQ:TXG) Trading Down 5.9%
marketbeat.com - April 16 at 1:41 PM
10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - April 16 at 7:22 AM
SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 15 at 10:06 PM
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.4710x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.47
marketbeat.com - April 15 at 2:48 PM
Cathie Woods ARK focuses on Teladoc and 10X Genomics stockCathie Wood's ARK focuses on Teladoc and 10X Genomics stock
investing.com - April 11 at 7:21 PM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
finance.yahoo.com - April 10 at 7:03 PM
10x Genomics (NASDAQ:TXG) Price Target Cut to $45.0010x Genomics (NASDAQ:TXG) Price Target Cut to $45.00
marketbeat.com - April 10 at 4:19 PM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
prnewswire.com - April 10 at 4:05 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down to $37.3710x Genomics (NASDAQ:TXG) Shares Gap Down to $37.37
marketbeat.com - April 10 at 11:50 AM
Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 9 at 12:12 PM
As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
genengnews.com - March 29 at 5:58 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

EQB logo

EQB

TSE:EQB
EQB Inc., through its subsidiary, Equitable Bank, provides personal and commercial banking services to retail and commercial customers in Canada. The company accepts term deposits and guaranteed investment certificates, high interest savings accounts, institutional deposit notes and covered bonds, as well as specialized financing solutions. It also offers residential mortgages, reverse mortgages, and home equity line of credit, as well as insurance loans. In addition, the company provides commercial loans, including business enterprise solutions for small-business owners, entrepreneurs, owner operators, and emerging investors; construction, bridge, or long-term financing; and structured financing solutions for specialty lenders across various asset classes of underbanked and unconventional industries. Further, it offers digital banking services. The company was formerly known as Equitable Group Inc. and changed its name to EQB Inc. in June 2022. EQB Inc. was founded in 1970 and is headquartered in Toronto, Canada.

38698 (GOR.V)

CVE:GOR
U.S. Global Sea to Sky Cargo ETF logo

U.S. Global Sea to Sky Cargo ETF

NYSEARCA:SEA
Guggenheim Shipping ETF (the Fund) seeks investment results that correspond generally to the performance of Delta Global Shipping Index (the Index). The Index is designed to measure the performance of companies listed on global developed market exchanges and consists of companies within the maritime shipping industry. The index provider, Delta Global Indices, LLC, defines the shipping industry to include companies within the business segments of the maritime shipping industry, such as companies deriving revenue from the seaborne transport of dry bulk goods and the leasing and/or operating of tanker ships, container ships, specialty chemical ships and ships that transport liquid natural gas (LNG) or dry bulk goods. The Fund will invest at least 90% of its total assets in common stock, American depositary receipts (ADRs), global depositary receipts (GDRs) and master limited partnerships (MLPs). The Fund's investment adviser is Guggenheim Funds Investment Advisors, LLC.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.